The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design (Q45347671)
Jump to navigation
Jump to search
scientific article published on 25 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design |
scientific article published on 25 February 2013 |
Statements
1 reference
The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design (English)
1 reference
Michael J Cousins
1 reference
Karen Pickthorn
1 reference
Saling Huang
1 reference
Linda Critchley
1 reference
Gregory Bell
1 reference
25 February 2013
1 reference
1 reference
14
1 reference
4
1 reference
533-540
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference